In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

Submit your partnership request with our easy-to-use online form. Join Dr. Strategic Partners Back to Partners List Submit Thanks for submitting!

Sudha Shenoy About Dr. Sudha Shenoy Dr. Sudha Shenoy is currently an Associate Professor in Medicine & Cell Biology in the Division of Cardiovascular Sudha Shenoy on the web Duke University Personal Reflections and Words of Wisdom: Story From Dr. Sudha Shenoy LinkedIn Pubmed Dr. GPCR Ecosystem Unlock the Full Dr.

Roger Sunahara About Dr. Roger Sunahara Professor Sunahara received his graduate training with Dr. In 2015 Professor Sunahara moved his laboratory to the Department of Pharmacology at the University of The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G Again, our intention is to target specific receptor subtypes. Roger Sunahara on the web UCSD Profile Google Scholar ResearchGate LinkedIn Dr.

Your tax-deductible donation supports education, collaboration, and innovation. Fueling Every Corner of the GPCR Ecosystem Every contribution directly supports the programs, tools, Happy Hours free or funding the next scholarship, your contribution makes a tangible difference. $25 Supporter Monthly donations sustain long-term programs and can be changed at any time through the donation form

Submit a problem! Get detailed information about incidents and find solutions. Join us today! Who is submitting this incident? Upload File Upload supported file (Max 15MB) Submit Thanks for submitting!

Take our quick 5-minute audience survey to help us tailor our content to your needs. GPCR Podcast Audience Survey Thanks for listening to this podcast episode Follow us on your favorite Podcast Player Be our Guest Listen and subscribe where you get your podcasts

Sudarshan Rajagopal About Dr. Sudarshan Rajagopal Dr. Sudarshan Rajagopal obtained his B.S. in Chemistry from The University of Chicago in 1998. He subsequently enrolled in the Medical Scientist Training Program at The University of Chicago. Sudarshan Rajagopal on the web LinkedIn Website Google Scholar LinkedIn Dr.

You're engaging directly with the expert — not submitting a question to a moderator. Bryan Roth Matteo Pavan Terry Kenakin Jakob Höppner Samuel Hoare Yamina Berchiche Kenneth Jacobson Sudarshan What came as a pleasant surprise was how didactical and well-thought-out his course was—highly recommended Also super-valuable for those of us learning how to teach pharmacology GPCR researcher Dr.

Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

They're designed for scientists who want deep, data-driven discussion rather than surface-level overviews

team Thanks for listening to this podcast episode Follow us on your favorite Podcast Player Listen and subscribe

and a conviction that the signaling space around a receptor is richer than single-pathway readouts suggest landscape of 90+ parallel vaccine candidates without confusing breadth of effort for probability of success This disease, for all its damage, is survivable for most people. The next one might not be. GPCR Summit 2020 announcement 01:49 Check-in with Dr. This disease, most people survive.

His group contributed to the de-orphanization of GPR139 and GPR55, including the identification of sub-nanomolar The full arc took more than a decade and required sustained coordination across disciplines that rarely This shift places data scientists and computational biologists in a newly central role - not as support The result was a structured group management model built around four specialized subgroups, each with a senior researcher as daily supervisor - a design that reduced bottlenecks and allowed the science

She subsequently joined Professor Mark Connor's laboratory at Macquarie University in Australia.

research focuses on bottom-up chemical tool development for imaging and interrogating GPCRs and other cell-surface Originally trained as a veterinary surgeon, he conducted postdoctoral research at the CNRS in Montpellier

Do you have any suggestions in terms of podcast equipment? Listen and subscribe where you get your podcasts

I am particularly interested in spatial signaling bias or how GPCRs can redistribute to different subcellular GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. Summary Podcast Recording and Science Backgrounds Yamina and Badr discussed recording their podcast with due to the support of a theater group and a good teacher. He also explained his strategy for finding a suitable postdoc lab, which involved reaching out to labs

Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well as suppliers

Episode Timeline Timestamps were generated using AI for readability. 00:00 Summit week welcome and episode And what surprised me even more was his lab was paying thousands of dollars for this legacy-looking software

He has received substantial, long-term support from international and national competitive, charitable GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. Summary Arthur's Career Journey and Transition to Dean Yamina introduced Arthur to her team and discussed the use of a particular tool for meeting summaries. Yamina expressed a desire to learn from successful leaders and the importance of recognizing talent and

field had not documented before: constitutive beta-arrestin activity at a wild-type FFA2 receptor, suppressible For Gilchrist, the result was not a surprise so much as a confirmation - if you look in the right system She also brings early industry experience from Pfizer, where her first sustained encounter with pharmacology Antibody therapeutics for GPCRs: the pipeline argument Biologics have a substantially higher success of drugging a receptor without knowing what activates it naturally, and getting therapeutic results, suggests

applications — as well as practical guidance on handling, reconstitution, dilution, and storage to support Available across multiple spectral ranges for confocal, super-resolution, and intravital imaging. daLUXendin Hodson is a veterinary surgeon by training who pursued postdoctoral studies at the CNRS in Montpellier The company's portfolio is built around high-affinity, selective fluorescent ligands for GPCRs, supporting

The four subtypes, A1, A2A, A2B, and A3, are expressed across virtually every tissue and implicated in One reason is that selectivity in this family is not just a matter of receptor subtype. pharmacology - the four subtypes, their G protein coupling profiles, and why ubiquity creates selectivity problems The tumor microenvironment and adenosine-mediated immune suppression - why A2A and A2B are During the conversation, an unresolved question surfaced: when a tagged receptor is transfected into

identifying ligands for orphan GPCRs by developing a powerful new computational tool for identifying ‘surrogate

Balenga "I received my Master’s degree from the University of Tehran, Iran, in 2005 by studying the suitability

Why peptide-based fluorescent ligands succeeded where antibodies repeatedly failed. Why targeting the pharmacologically relevant surface-exposed receptor pool changes the way scientists The moment when super-resolution imaging revealed nanoscale receptor domains that conventional tools FMP) in Berlin, focusing on developing fluorescent chemical tools to visualize GPCRs and other cell-surface